Aspen Pharmacare Holdings Ltd (APN.JSE) stock research preview
A public snapshot of Aspen Pharmacare Holdings Ltd. Create an account to continue into the full research workspace with valuation, risks, news context, watchlists, and AI chat.
Latest share price
R146.75
Close on Jun 17, 2026
Share price history
Daily close preview from public data.
Company overview
Healthcare / Drug Manufacturers - Specialty & Generic
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xyl...
- Country
- South Africa
- ISIN
- ZAE000066692
- Fiscal year end
- June
- Instrument type
- Common Stock
Investment snapshot
Selected public metrics from loaded fundamentals.
Market cap
65.5B
P/E
n/a
Revenue TTM
42.6B
Profit margin
-4.69%
Revenue growth YoY
-4.3%
Dividend yield
0.01%
Decision brief
AI-assisted stance, supporting evidence, concerns, and watch items.
News context
Recent company news synthesized into the research thesis.
Research chat
Ask follow-up questions about APN.JSE valuation, risks, and catalysts.